MARKET

BCTXL

BCTXL

Briacell Therapeutics Corp
NASDAQ
1.025
-0.065
-5.96%
Closed 15:43 05/12 EDT
OPEN
1.050
PREV CLOSE
1.090
HIGH
1.050
LOW
1.000
VOLUME
2.18K
TURNOVER
--
52 WEEK HIGH
1.400
52 WEEK LOW
0.6500
MARKET CAP
--
P/E (TTM)
-0.0315
1D
5D
1M
3M
1Y
5Y
1D
BriaCell Phase 3 Bria-IMT breast cancer trial enrollment tops 230 patients
PUBT · 22h ago
BRIACELL THERAPEUTICS CORP - INTERIM TOPLINE DATA FROM PHASE 3 BRIA-ABC STUDY EXPECTED IN 2026
Reuters · 22h ago
BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients
Barchart · 1d ago
BriaCell adds NYU Langone Perlmutter as site for Phase 3 breast cancer trial
PUBT · 5d ago
BRIACELL ADDS NYU LANGONE HEALTH’S PERLMUTTER CANCER CENTER AS CLINICAL SITE IN PIVOTAL PHASE 3 BREAST CANCER STUDY
Reuters · 5d ago
BriaCell wins FDA clearance to start Bria-BRES+ metastatic breast cancer study
PUBT · 6d ago
BRIACELL THERAPEUTICS CORP - TO INITIATE PHASE 1/2A STUDY OF BRIA-BRES+ IN COMING MONTHS
Reuters · 6d ago
BriaCell to present final Phase 2 Bria-IMT survival data at ASCO 2026
PUBT · 04/27 11:30
More

Webull offers Briacell Therapeutics Corp stock information, including NASDAQ: BCTXL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTXL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCTXL stock methods without spending real money on the virtual paper trading platform.